PL2678032T3 - Wektory lentiwirusowe zawierające promotor MHC klasy I - Google Patents

Wektory lentiwirusowe zawierające promotor MHC klasy I

Info

Publication number
PL2678032T3
PL2678032T3 PL13720364T PL13720364T PL2678032T3 PL 2678032 T3 PL2678032 T3 PL 2678032T3 PL 13720364 T PL13720364 T PL 13720364T PL 13720364 T PL13720364 T PL 13720364T PL 2678032 T3 PL2678032 T3 PL 2678032T3
Authority
PL
Poland
Prior art keywords
promoter
mhc class
vectors containing
lentiviral vectors
lentiviral
Prior art date
Application number
PL13720364T
Other languages
English (en)
Inventor
Emeline Sarry
Cécile Bauche
Original Assignee
Theravectys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravectys filed Critical Theravectys
Publication of PL2678032T3 publication Critical patent/PL2678032T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041Use of virus, viral particle or viral elements as a vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL13720364T 2012-05-23 2013-04-30 Wektory lentiwirusowe zawierające promotor MHC klasy I PL2678032T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305566.7A EP2666477A1 (en) 2012-05-23 2012-05-23 Lentiviral vectors containing an MHC class I promoter
PCT/EP2013/059041 WO2013174630A1 (en) 2012-05-23 2013-04-30 Lentiviral vectors containing an mhc class i promoter
EP13720364.2A EP2678032B1 (en) 2012-05-23 2013-04-30 Lentiviral vectors containing an mhc class i promoter

Publications (1)

Publication Number Publication Date
PL2678032T3 true PL2678032T3 (pl) 2014-11-28

Family

ID=48289150

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13720364T PL2678032T3 (pl) 2012-05-23 2013-04-30 Wektory lentiwirusowe zawierające promotor MHC klasy I

Country Status (18)

Country Link
US (1) US8951535B2 (pl)
EP (2) EP2666477A1 (pl)
JP (1) JP5938143B2 (pl)
KR (1) KR101774929B1 (pl)
CN (1) CN104736167B (pl)
AU (1) AU2013265586B2 (pl)
BR (1) BR112014028944B1 (pl)
CA (1) CA2873473C (pl)
ES (1) ES2498277T3 (pl)
HK (1) HK1211837A1 (pl)
IL (1) IL235705A (pl)
IN (1) IN2014DN10123A (pl)
NZ (1) NZ702345A (pl)
PL (1) PL2678032T3 (pl)
PT (1) PT2678032E (pl)
SG (1) SG11201407732SA (pl)
WO (1) WO2013174630A1 (pl)
ZA (1) ZA201408652B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014277092B2 (en) 2013-06-03 2019-04-04 Theravectys Lentiviral vectors containing an MHC class I, MHC class II, or beta-2 microglobulin upstream promoter sequence
EP3276006A1 (en) * 2016-07-27 2018-01-31 Theravectys Lentiviral vectors for expression of hepatitis b virus (hbv) antigens
KR20220005208A (ko) 2020-07-06 2022-01-13 주식회사 지씨셀 면역원성이 감소된 신규한 이식용 세포
CN114107393A (zh) 2021-04-07 2022-03-01 上海劲威生物科技有限公司 一种治疗乙型肝炎的慢病毒载体、慢病毒颗粒及其制备方法和应用
KR20240073177A (ko) * 2022-11-10 2024-05-24 전남대학교산학협력단 다중에피토프 펩타이드를 포함하는 신경교종 예방 또는 치료용 약제학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19720152A1 (de) * 1997-05-02 1998-11-05 Max Delbrueck Centrum Retrovirales Vektorsystem zur Optimierung des Gentransfers und der Genexpression in primären humanen T-Lymphozyten
FR2777909B1 (fr) 1998-04-24 2002-08-02 Pasteur Institut Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex
ATE449858T1 (de) * 1999-10-11 2009-12-15 Pasteur Institut Lentivirale vektoren für die herstellung von immunotherapeutischen zusammensetzungen
EP1792997B1 (en) 1999-10-12 2011-11-02 Institut Pasteur Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
FR2870126B1 (fr) 2004-05-17 2009-07-17 Pasteur Institut Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin
US8222029B2 (en) 2005-05-16 2012-07-17 Institut Pasteur Lentiviral vector-based vaccine
PT2185192T (pt) 2007-08-03 2019-02-12 Pasteur Institut Vetores de transferência de genes lentivirais e suas aplicações medicinais

Also Published As

Publication number Publication date
AU2013265586B2 (en) 2015-09-03
SG11201407732SA (en) 2014-12-30
CN104736167A (zh) 2015-06-24
IN2014DN10123A (pl) 2015-08-21
BR112014028944A2 (pt) 2015-09-29
EP2678032B1 (en) 2014-06-18
AU2013265586A1 (en) 2014-12-11
EP2678032A1 (en) 2014-01-01
ES2498277T3 (es) 2014-09-24
IL235705A0 (en) 2015-01-29
BR112014028944B1 (pt) 2020-11-10
US20140120132A1 (en) 2014-05-01
WO2013174630A1 (en) 2013-11-28
HK1211837A1 (en) 2016-06-03
CA2873473C (en) 2019-05-07
EP2666477A1 (en) 2013-11-27
KR20150014472A (ko) 2015-02-06
PT2678032E (pt) 2014-09-09
IL235705A (en) 2016-10-31
JP5938143B2 (ja) 2016-06-22
US8951535B2 (en) 2015-02-10
NZ702345A (en) 2016-03-31
KR101774929B1 (ko) 2017-09-19
CN104736167B (zh) 2018-07-27
ZA201408652B (en) 2016-09-28
JP2015518716A (ja) 2015-07-06
CA2873473A1 (en) 2013-11-28

Similar Documents

Publication Publication Date Title
HK1209660A1 (en) Auto-injector
EP2909324A4 (en) RETROVIRAL VECTOR WITH MINI-PROMOTER CASSETTE
EP3586971C0 (en) CENTRIFUGE
PL2935848T3 (pl) Materiały pędne sterowane elektrycznie
PL2809297T3 (pl) Nowy układ fotoochronny
EP2829285A4 (en) FORMULATION WITH A RECOMBINANT LENTIVIRAL VECTOR
IL225369A0 (en) Improved padded cables
GB201220885D0 (en) An improved deployment mechanism
EP2848687A4 (en) NOVEL EXPRESSION VECTOR
EP2812436A4 (en) MINI-INTRONIC PLASMID VECTORS
ZA201504003B (en) Stabilizing system
HK1205288A1 (en) Flexible lever-free escapement mechanism
HK1211837A1 (en) Lentiviral vectors containing an mhc class i promoter mhc i
PL2861074T3 (pl) Środek przerzedzający zawierający diuron
IL238627B (en) Peptides containing a sequence derived from fviii
SG11201503897XA (en) Peroxide masterbatch based on bioresin
PT2677615T (pt) Passa-fios
GB201220119D0 (en) Vector
ZA201406433B (en) Oxidizer solution
PL2722268T3 (pl) Łódź podwodna
GB201203130D0 (en) An organiser
EP2933331A4 (en) EXPRESSION CASSETTE
PT2842801T (pt) Um mecanismo de apoio de braço
GB201205795D0 (en) Vector
GB201214413D0 (en) Festivalstand (festistand)